These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7585604)

  • 21. [Deletions and aberrant transcription of p16 and p15 genes in childhood acute lymphoblastic leukemia].
    Fu G; Lu C; Zhang R
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):366-8. PubMed ID: 11721435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
    Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN
    Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia.
    Stegmaier K; Takeuchi S; Golub TR; Bohlander SK; Bartram CR; Koeffler HP
    Cancer Res; 1996 Mar; 56(6):1413-7. PubMed ID: 8640833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
    Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Allelic loss of 6q16.3 microsatellite DNA in childhood acute lymphoblastic leukemia and bioinformatics analysis].
    Yang MH; Cao LZ; Yu Y; Zhang ZX; Wang Y; Kang R; Chen Y; Tan ZH; Wu XS
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):289-93. PubMed ID: 16875573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis.
    Takeuchi S; Koike M; Seriu T; Bartram CR; Slater J; Park S; Miyoshi I; Koeffler HP
    Leukemia; 1997 Oct; 11(10):1636-40. PubMed ID: 9324282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allelic loss in childhood acute lymphoblastic leukemia.
    Baccichet A; Qualman SK; Sinnett D
    Leuk Res; 1997 Sep; 21(9):817-23. PubMed ID: 9393596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas.
    Li YJ; Hoang-Xuan K; Delattre JY; Poisson M; Thomas G; Hamelin R
    Oncogene; 1995 Aug; 11(3):597-600. PubMed ID: 7630644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inverse correlation between loss of heterozygosity of the short arm of chromosome 12 and p15ink4B/p16ink4 gene inactivation in childhood acute lymphoblastic leukaemia.
    Heyman M; Calero Moreno T; Liu Y; Grandér D; Rasool O; Borgonova-Brandter L; Merup M; Söderhäll S; Einhorn S
    Br J Haematol; 1997 Jul; 98(1):147-50. PubMed ID: 9233578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.
    Obermann EC; Diss TC; Hamoudi RA; Munson P; Wilkins BS; Camozzi ML; Isaacson PG; Du MQ; Dogan A
    J Pathol; 2004 Feb; 202(2):252-62. PubMed ID: 14743509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial allelotype of carcinoma in situ of the human bladder.
    Rosin MP; Cairns P; Epstein JI; Schoenberg MP; Sidransky D
    Cancer Res; 1995 Nov; 55(22):5213-6. PubMed ID: 7585577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute lymphoblastic leukemia of childhood: identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1.
    Takeuchi S; Bartram CR; Miller CW; Reiter A; Seriu T; Zimmerann M; Schrappe M; Mori N; Slater J; Miyoshi I; Koeffler HP
    Blood; 1996 Apr; 87(8):3368-74. PubMed ID: 8605354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B-cell non-Hodgkin's lymphoma.
    Nagai H; Kinoshita T; Suzuki H; Hatano S; Murate T; Saito H
    Genes Chromosomes Cancer; 1999 Jul; 25(3):277-83. PubMed ID: 10379874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma.
    Wistuba II; Tang M; Maitra A; Alvarez H; Troncoso P; Pimentel F; Gazdar AF
    Cancer Res; 2001 May; 61(9):3795-800. PubMed ID: 11325854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rare loss of heterozygosity of the MTS1 and MTS2 tumor suppressor genes in differentiated human thyroid cancer.
    Schulte KM; Staudt S; Niederacher D; Finken-Eigen M; Köhrer K; Goretzki PE; Röher HD
    Horm Metab Res; 1998 Sep; 30(9):549-54. PubMed ID: 9808321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.
    Batova A; Diccianni MB; Yu JC; Nobori T; Link MP; Pullen J; Yu AL
    Cancer Res; 1997 Mar; 57(5):832-6. PubMed ID: 9041181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
    Brenner AJ; Aldaz CM
    Cancer Res; 1995 Jul; 55(13):2892-5. PubMed ID: 7796417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.